Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death

Gastroenterology

Volumn 156, Issue 1, 2019, Pages 63-74.e6

  Doubeni, Chyke A ^a   Fedewa, Stacey A ^b   Levin, Theodore R ^c   Jensen, Christopher D ^c   Saia, Chelsea ^a   Zebrowski, Alexis M ^a   Quinn, Virginia P ^d   Rendle, Katharine A ^a   Zauber, Ann G ^e   Becerra Culqui, Tracy A ^d   Mehta, Shivan J ^f   Fletcher, Robert H ^g   Schottinger, Joanne ^d   Corley, Douglas A ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c DIVISION OF RESEARCH   (United States)

^d KAISER PERMANENTE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenoma; Cancer Prevention; Colon Cancer; Early Detection

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER THERAPY; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; DATA BASE; DEATH; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYPECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGMOIDOSCOPY; VERY ELDERLY; ADENOCARCINOMA; CALIFORNIA; CAUSE OF DEATH; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; MORTALITY; PATIENT ATTITUDE; PREDICTIVE VALUE; PROTECTION; REPRODUCIBILITY; RISK FACTOR; TIME FACTOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CALIFORNIA; CAUSE OF DEATH; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PROTECTIVE FACTORS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 85058463692     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2018.09.040     Document Type: Article

References (49)

1. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2018. CA Cancer J Clin 68 (2018), 7–30.
2. Arnold, M., Sierra, M.S., Laversanne, M., et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66 (2017), 683–691.
3. Hewitson, P., Glasziou, P., Watson, E., et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103 (2008), 1541–1549.
4. Lieberman, D.A., Rex, D.K., Winawer, S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143 (2012), 844–857.
5. US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D.C., Curry, S.J., et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315 (2016), 2564–2575.
6. Rex, D.K., Boland, C.R., Dominitz, J.A., et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 153 (2017), 307–323.
7. Tiro, J.A., Kamineni, A., Levin, T.R., et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev 23 (2014), 1147–1158.
8. Chubak, J., Garcia, M.P., Burnett-Hartman, A.N., et al. Time to colonoscopy after positive fecal blood test in four U.S. health care systems. Cancer Epidemiol Biomarkers Prev 25 (2016), 344–350.
9. Corley, D.A., Jensen, C.D., Quinn, V.P., et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA 317 (2017), 1631–1641.
10. Doubeni, C.A., Gabler, N.B., Wheeler, C.M., et al. Timely follow-up of positive cancer screening results: a systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin 68 (2018), 199–216.
11. Corley, D.A., Jensen, C.D., Marks, A.R., et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370 (2014), 1298–1306.
12. Zapka, J.G., Taplin, S.H., Solberg, L.I., et al. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev 12 (2003), 4–13.
13. Taplin, S.H., Ichikawa, L., Yood, M.U., et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?. J Natl Cancer Inst 96 (2004), 1518–1527.
14. Leyden, W.A., Manos, M.M., Geiger, A.M., et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 97 (2005), 675–683.
15. Meester, R.G., Doubeni, C.A., Lansdorp-Vogelaar, I., et al. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol 25 (2015), 208–213 e1.
16. Levin, T.R., Jamieson, L., Burley, D.A., et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 33 (2011), 101–110.
17. Mehta, S.J., Jensen, C.D., Quinn, V.P., et al. Race/ethnicity and adoption of a population health management approach to colorectal cancer screening in a community-based healthcare system. J Gen Intern Med 31 (2016), 1323–1330.
18. Sabatino, S.A., White, M.C., Thompson, T.D., et al. Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 64 (2015), 464–468.
19. de Moor, J.S., Cohen, R.A., Shapiro, J.A., et al. Colorectal cancer screening in the United States: trends from 2008 to 2015 and variation by health insurance coverage. Prev Med 112 (2018), 199–206.
20. Doubeni, C.A., Corley, D.A., Quinn, V.P., et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut 67 (2018), 291–298.
21. Goodman, M., Fletcher, R.H., Doria-Rose, V.P., et al. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res 4 (2015), 541–551.
22. Doubeni, C.A., Corley, D.A., Zauber, A.G., Colorectal cancer health disparities and the role of US law and health policy. Gastroenterology 150 (2016), 1052–1055.
23. Doubeni, C.A., Schootman, M., Major, J.M., et al. Health status, neighborhood socioeconomic context, and premature mortality in the United States: the National Institutes of Health–AARP Diet and Health Study. Am J Public Health 102 (2012), 680–688.
24. Doubeni, C.A., Jambaulikar, G.D., Fouayzi, H., et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population—a retrospective cohort study. PLoS One, 7, 2012, e36392.
25. Fassil, H., Adams, K.F., Weinmann, S., et al. Approaches for classifying the indications for colonoscopy using detailed clinical data. BMC Cancer, 14, 2014, 95.
26. Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008), 1570–1595.
27. Lieberman, D.A., Williams, J.L., Holub, J.L., et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc 80 (2014), 133–143.
28. Nishihara, R., Wu, K., Lochhead, P., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
29. Schoen, R.E., Pinsky, P.F., Weissfeld, J.L., et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366 (2012), 2345–2357.
30. Segnan, N., Armaroli, P., Bonelli, L., et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial—SCORE. J Natl Cancer Inst 103 (2011), 1310–1322.
31. Atkin, W., Wooldrage, K., Parkin, D.M., et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet 389 (2017), 1299–1311.
32. Sabatino, S.A., Lawrence, B., Elder, R., et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med 43 (2012), 97–118.
33. Guessous, I., Dash, C., Lapin, P., et al. Colorectal cancer screening barriers and facilitators in older persons. Prev Med 50 (2010), 3–10.
34. Green, B.B., Anderson, M.L., Cook, A.J., et al. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: a randomized trial. Cancer 123 (2017), 4472–4480.
35. Weissfeld, J.L., Schoen, R.E., Pinsky, P.F., et al. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst 104 (2012), 280–289.
36. Fisher, D.A., Jeffreys, A., Coffman, C.J., et al. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev 15 (2006), 1232–1235.
37. Baig, N., Myers, R.E., Turner, B.J., et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol 98 (2003), 2078–2081.
38. Carlson, C.M., Kirby, K.A., Casadei, M.A., et al. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?. Arch Intern Med 171 (2011), 249–256.
39. Selby, K., Baumgartner, C., Levin, T.R., et al. Interventions to improve follow-up of positive results on fecal blood tests: a systematic review. Ann Intern Med 167 (2017), 565–575.
40. Atkins, L., Hunkeler, E.M., Jensen, C.D., et al. Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. Gastrointest Endosc 83 (2016), 617–626 e2.
41. Fedewa, S.A., Flanders, W.D., Ward, K.C., et al. Racial and ethnic disparities in interval colorectal cancer incidence: a population-based cohort study. Ann Intern Med 166 (2017), 857–866.
42. Doubeni, C.A., Jensen, C.D., Fedewa, S.A., et al. Fecal immunochemical test (FIT) for colon cancer screening: variable performance with ambient temperature. J Am Board Fam Med 29 (2016), 672–681.
43. Baxter, N.N., Goldwasser, M.A., Paszat, L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009), 1–8.
44. Doubeni, C.A., Weinmann, S., Adams, K., et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 158 (2013), 312–320.
45. Biagi, J.J., Raphael, M.J., Mackillop, W.J., et al. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA 305 (2011), 2335–2342.
46. Bosset, J.F., Collette, L., Calais, G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006), 1114–1123.
47. Edwards, B.K., Ward, E., Kohler, B.A., et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116 (2010), 544–573.
48. Fedewa, S.A., Goodman, M., Flanders, W.D., et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer 121 (2015), 3272–3280.
49. Levin, T.R., Corley, D.A., Jensen, C.D., et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large, community-based population. Gastroenterology 155 (2018), 1383–1391.e5.